Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2019 1
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study.
Lanas Á, Balaguer F, Sánchez-Luengo M, Hijos-Mallada G, Hernández-Mesa G, Piñero M, Castillo J, Ocaña T, Cubiella J, Crespo A, Iglesias Á, Medeiros I, Cacho G, Jover-Martínez R, Alustiza M, Diaz-Tasende J, Poves C, Macedo G, Quintero E; Advantage study group. Lanas Á, et al. Among authors: jover martinez r. United European Gastroenterol J. 2023 Sep;11(7):692-699. doi: 10.1002/ueg2.12446. Epub 2023 Aug 23. United European Gastroenterol J. 2023. PMID: 37614054 Free PMC article.
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
Danese S, Colombel JF, Lukas M, Gisbert JP, D'Haens G, Hayee B, Panaccione R, Kim HS, Reinisch W, Tyrrell H, Oh YS, Tole S, Chai A, Chamberlain-James K, Tang MT, Schreiber S; GARDENIA Study Group. Danese S, et al. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):118-127. doi: 10.1016/S2468-1253(21)00294-6. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798038 Free article. Clinical Trial.
The challenge of quantifying screening colonoscopy quality: Development and psychometric properties of the Colonoscopy Quality Score instrument.
Sáenz-Fuenzalida R, Riquelme-Pérez A, Díaz-Piga LA, García-Rocha X, Fuentes-López E, Arnold-Álvarez J, Caro L, Tchekmedyian A, Orellana-Narváez I, Jover-Martínez R; el Equipo Latinoamericano para el Sistema de Escala de Calidad en Colonoscopía. Sáenz-Fuenzalida R, et al. Among authors: jover martinez r. Rev Gastroenterol Mex (Engl Ed). 2022 Jul-Sep;87(3):297-304. doi: 10.1016/j.rgmxen.2021.11.005. Epub 2021 Nov 16. Rev Gastroenterol Mex (Engl Ed). 2022. PMID: 34794928 Free article.
The challenge of quantifying screening colonoscopy quality: Development and psychometric properties of the Colonoscopy Quality Score instrument.
Sáenz-Fuenzalida R, Riquelme-Pérez A, Díaz-Piga LA, García-Rocha X, Fuentes-López E, Arnold-Álvarez J, Caro L, Tchekmedyian A, Orellana-Narváez I, Jover-Martínez R; el Equipo Latinoamericano para el Sistema de Escala de Calidad en Colonoscopía. Sáenz-Fuenzalida R, et al. Among authors: jover martinez r. Rev Gastroenterol Mex (Engl Ed). 2021 Jul 23:S0375-0906(21)00068-9. doi: 10.1016/j.rgmx.2021.01.011. Online ahead of print. Rev Gastroenterol Mex (Engl Ed). 2021. PMID: 34312017 Free article. English, Spanish.
[Advances in colorectal cancer screening].
Jover Martínez R. Jover Martínez R. Gastroenterol Hepatol. 2008 Oct;31 Suppl 4:62-5. doi: 10.1016/s0210-5705(08)76632-9. Gastroenterol Hepatol. 2008. PMID: 19434869 Spanish.